Schizoaffective Disorders Completed Phase 4 Trials for Galantamine (DB00674)

Also known as: Schizoaffective disorder / Schizophrenia schizoaffective / Schizoaffective psychosis / Schizo-affective type schizophrenia

IndicationStatusPhase
DBCOND0033299 (Schizoaffective Disorders)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00176423Efficacy Study of Galantamine for Cognitive Impairments in SchizophreniaTreatment
NCT00320736Galantamine for Cognition in People With SchizophreniaTreatment